CytoSorbents Corporation

Medical Equipment ManufacturingNew Jersey, United States51-200 Employees

CytoSorbents Corporation, based in Princeton, New Jersey, develops and commercializes medical devices that use a proprietary polymer adsorption technology to purify blood. Its flagship CytoSorb device is used in intensive care and cardiac surgery to mitigate life-threatening conditions by removing inflammatory mediators and other harmful substances from blood, and it is distributed in more than 70 countries with CE Mark coverage in the EU for cytokine, bilirubin and myoglobin removal in critical-care applications, and for ticagrelor and rivaroxaban removal during cardiothoracic surgery. The company is pursuing FDA marketing approval in the United States for antithrombotic removal in cardiothoracic surgery through two pivotal randomized trials of its DrugSorb-ATR system. 
 
 CytoSorbents operates in the medical equipment manufacturing sector, serving hospitals and critical-care centers seeking blood purification therapies to improve outcomes in ICU and surgical settings. Recent developments announced in 2026 include ISICEM-related announcements of the HotSwap launch and a renewed partnership with Aferetica, as well as collaboration to integrate its PerSorb cartridge with organ preservation platforms.

Sign up for free to view info

Email Format Employee directory